Abbott India share news, announcements and annual reports
NSE: ABBOTINDIABSE: 500488Pharmaceuticals & BiotechnologyMid Cap
Abbott India Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1966
Last close ₹25,820.00up ₹185.00 (0.72%)BSE ₹25,783.50
Share price at the NSE close on 2 Nov 2026. Previous close ₹25,635.00.
2 Nov: open ₹25,850.00, high ₹25,930.00, low ₹25,630.00
52-week range of traded prices to 2 Nov 2026
₹24,650.00Low, 23 Oct 2026₹30,655.00High, 25 Nov 2025
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹54,866 Cr183rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 33.98
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.49
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.54%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 35.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 39.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,06248.6% delivered
Abbott India board meetings
90 filed, newest first. Page 2 of 2.
Jan 2021
29 Jan · Board meeting
Meeting on 9 Feb 2021: quarterly results
Nov 2020
2 Nov · Board meeting
Meeting on 11 Nov 2020: quarterly results
Jul 2020
30 Jul · Board meeting
Meeting on 7 Aug 2020: quarterly results
May 2020
29 May · Board meeting
Meeting on 8 Jun 2020: dividend, final dividend, special dividend and audited results
Jan 2020
21 Jan · Board meeting
Meeting on 7 Feb 2020: quarterly results
Oct 2019
31 Oct · Board meeting
Meeting on 12 Nov 2019: quarterly results
Jul 2019
29 Jul · Board meeting
Meeting on 8 Aug 2019: quarterly results
May 2019
10 May · Board meeting
Meeting on 27 May 2019: final dividend, dividend, special dividend and audited results
Jan 2019
23 Jan · Board meeting
Meeting on 8 Feb 2019: quarterly results
Nov 2018
Aug 2018
13 Aug · Board meeting
May 2018
14 May · Board meeting
4 May · Board meeting
Feb 2018
14 Feb · Board meeting
Nov 2017
13 Nov · Board meeting
Aug 2017
8 Aug · Board meeting
May 2017
May 2016
11 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 25, 2016, inter alia, for the following: 1. To consider and approve ....
May 2015
18 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 27, 2015, inter alia, for the following: 1. To consider and approve ....
May 2014
28 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2014, have recommended the appointment of M/s S.R.B.C. & CO. LLP, Chartered Accountants, ....21 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 27, 2014, inter alia, for the following; 1. To consider and approve ....
Nov 2013
7 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 07, 2013 decided to change the accounting year of the Company from year ending ....
Jun 2013
4 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 03, 2013, has decided to defer the proposal received by the Company for the sale ....
Feb 2013
20 Feb · Board meeting
1. Mr. Laurent Van Lerberghe and Mr. Ramon F. Neira Hoyos resigned as Directors effective February 20, 2013. 2. The Board, at its meeting ....13 Feb · Board meeting
Meeting of the Board of Directors of the Company will be held on February 20, 2013, inter alia, for the following: 1. To consider and approve ....
Mar 2011
3 Mar · Board meeting
Board of Directors of the Company at its meeting held on February 28, 2011, has appointed following Additional Directors: 1. Mr. Kaiyomarz Marfatia ....
Feb 2011
21 Feb · Board meeting
Meeting of the Board of Directors of the Company will be held on February 28, 2011, inter alia, for the following: 1. To consider and approve ....
Nov 2010
24 Nov · Board meeting
Boards of Directors of Abbott India Ltd. ("Abbott India") and Solvay Pharma India Ltd. ("Solvay Pharma India"), at their meetings held on November ....
Jan 2010
25 Jan · Board meeting
Meeting of the Board of Directors of the Company will be held on February 01, 2010, inter alia, for the following: 1. To consider and approve ....